We are closed 11/28 & 11/29 due to the Thanksgiving holiday. This includes both offices (Rockville and Olney) and the lab. We will resume normal business hours on Monday 12/2/24.
Proudly Part of Privia Health
RIMG is now offering the 2024-2025 flu vaccine. Unfortunately, we do not have the newest COVID booster at this time or the RSV vaccine. You may obtain at your local pharmacy.
How to Schedule a Flu Vaccine: Follow this link to schedule for our current vaccine clinic available at Olney and Rockville offices through October. Or you may call the Rockville office at 301-762-5020 or Olney office at 301-933-5050 to schedule. You may also receive during any in-office appointment or at your local pharmacy.
**You may receive the COVID and Flu vaccine together, but it is recommended to separate the RSV vaccine by 1-2 weeks.**
**********************************************************************************************************
2024 COVID-Vaccine Information (*not available at RIMG*) :
The 2024–2025 formulation for Moderna and Pfizer-BioNTech COVID-19 vaccines has been updated to a monovalent vaccine based on the Omicron JN.1-lineage of SARS-CoV-2, KP.2. Vaccination is especially important for people at highest risk of severe COVID-19, including those 65 years and older, people with underlying medical conditions, those in long-term care facilities, and pregnant individuals.
If you’ve had a recent COVID infection, the CDC states you may wait at least 3 months to receive a COVID booster.
All ages are eligible for an updated COVID-19 vaccine if its been at least 4 months since last vaccination, but it is especially important for those over 65 or immunocompromised.
*Immunocompromised individuals may receive a booster more often as soon as 2 months since last vaccination*
*************************************************************************************************************
2024 Flu Vaccine Information:
The single best way to prevent seasonal flu is to get the flu vaccine each year.
In addition, you can practice healthy habits by avoiding close contact with people who are sick, staying at home when you are sick, covering your mouth and nose when coughing or sneezing and washing your hands often.
We are offering the Fluzone High Dose Quadrivalent vaccine for 65 and older, the Flublok vaccine for ages 50-64 and the Fluzone vaccine for those under 50. All of our flu vaccines are preservative free and safe for those with an egg allergy.
***********************************************************************************************************
RSV Vaccine Information (*not available at RIMG*) :
The CDC recommends that everyone age 75 and older receive the RSV vaccine. People ages 60–74 who are at increased risk of severe RSV should receive the vaccine. This includes those with:
Certain chronic medical conditions (e.g., lung disease, heart disease, diabetes with end-organ damage)
Those living in nursing homes
The CDC recommends the Pfizer RSV vaccine (Abrysvo) for pregnant women during 32 through 36 weeks gestation to provide protection for newborns from birth to 6 months of age.
The RSV vaccine is not currently an annual vaccine for adults. If you’ve already received an RSV vaccine, you don’t need to get another one at this time.
*************************************************************************************************************
If you are currently ill with COVID, have COVID symptoms please schedule a virtual visit ASAP or do a virtual visit on demand. We have same day COVID PCR testing available for our patients *by appointment only.* If you need a COVID test and are not currently symptomatic, please call the office and we can help you schedule.
Please see this recently updated link from the CDC on isolation with illnesses including COVID, FLU, RSV and other upper respiratory infections.
There are treatments authorized for COVID-19 for individuals who are at high risk of progressing to severe COVID-19 as defined by the CDC. An appointment is required for a prescription and our providers are following the CDC guidelines for identifying high risk patients who may benefit from treatment.